American Journal of Bioethics 14 (10):7-18 (2014)

Advocates of paid living kidney donation frequently argue that kidney sellers would benefit from paid donation under a properly regulated kidney market. The poor outcomes experienced by participants in existing markets are often entirely attributed to harmful black-market practices. This article reviews the medical and anthropological literature on the physical, psychological, social, and financial harms experienced by vendors under Iran's regulated system of donor compensation and black markets throughout the world and argues that this body of research not only documents significant harms to vendors, but also provides reasons to believe that such harms would persist under a regulated system. This does not settle the question of whether or not a regulated market should be introduced, but it does strengthen the case against markets in kidneys while suggesting that those advocating such a system cannot appeal to the purported benefits to vendors to support their case.
Keywords No keywords specified (fix it)
Categories (categorize this paper)
DOI 10.1080/15265161.2014.947041
Edit this record
Mark as duplicate
Export citation
Find it on Scholar
Request removal from index
Revision history

Download options

PhilArchive copy

Upload a copy of this paper     Check publisher's policy     Papers currently archived: 64,159
External links

Setup an account with your affiliations in order to access resources via your University's proxy server
Configure custom proxy (use this if your affiliation does not provide a proxy)
Through your library

References found in this work BETA

View all 24 references / Add more references

Citations of this work BETA

Commodification and Human Interests.Julian Koplin - 2018 - Journal of Bioethical Inquiry 15 (3):429-440.
Reassessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Luke Semrau - 2017 - Journal of Medicine and Philosophy 42 (6):634-652.

View all 29 citations / Add more citations

Similar books and articles

Avoiding Harms to Kidney Vendors Through Legal, Regulated Markets.James Taylor - 2014 - American Journal of Bioethics 14 (10):21-22.
In Defense of a Regulated Market in Kidneys From Living Vendors.Benjamin E. Hippen - 2005 - Journal of Medicine and Philosophy 30 (6):593 – 626.
Autonomy, Moral Constraints, and Markets in Kidneys.S. J. Kerstein - 2009 - Journal of Medicine and Philosophy 34 (6):573-585.
Kidney Sales and the Analogy with Dangerous Employment.Erik Malmqvist - 2015 - Health Care Analysis 23 (2):107-121.
Ambivalence, Autonomy, and Organ Sales.Paul M. Hughes - 2006 - Southern Journal of Philosophy 44 (2):237-251.
Organ Markets and the Ends of Medicine.F. D. Davis & S. J. Crowe - 2009 - Journal of Medicine and Philosophy 34 (6):586-605.


Added to PP index

Total views
74 ( #146,542 of 2,454,809 )

Recent downloads (6 months)
1 ( #449,241 of 2,454,809 )

How can I increase my downloads?


My notes